Is Shiva Pharmachem Ltd a good quality company?

Data is not available for this company.

What is Shiva Pharmachem Ltd share price return in the past 10 years?

Data is not available for this company

What is the share price of Shiva Pharmachem Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Shiva Pharmachem Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Shiva Pharmachem?

The latest standalone P/E ratio of Shiva Pharmachem as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Shiva Pharmachem Ltd?

The latest standalone P/B ratio of Shiva Pharmachem Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Shiva Pharmachem Ltd?

The 52-week high of Shiva Pharmachem Ltd is Rs. and the 52-week low is Rs. .

Shiva Pharmachem Ltd Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Shiva Pharmachem Ltd
Brand: Shiva Pharmachem

Shiva Pharmachem Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹0 Cr.

P/E Ratio

0.00

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Return on Capital Employed (ROCE)

21.89%

Current Price

₹0

Return on Equity (ROE)

21.86%

Return on Assets (ROA)

11.98%

Operating Profit Margin

20.4%

Net Profit Margin

11.7%

Gross Profit Margin

20.8%

Book Value per Share

₹0

Sales Growth (YoY)

7.49%

Sales Growth (3 Years)

5.98%

Operating Profit Growth (1 Year)

17.82%

Operating Profit Growth (3 Years)

-1.59%

Net Profit Growth (1 Year)

19.29%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

-98.09%

Dividend Yield

0.00%

Promoter Holding

Pledged shares (%)
of Promoter's holding (%)

DeciZen - make an informed investing decision on Shiva Pharmachem

Based on:

Data

DeciZen not available for IPO

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	28.8%	11.9%	10.3%	3.5%	6.5%	22.9%	39.2%	22.1%	21.6%	21.9%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	490	470	413	422	495	706	640	528	709	762	706
Sales YoY Gr.	-	-4.2%	-12.1%	2.1%	17.3%	42.6%	-9.4%	-17.5%	34.3%	7.5%	-
Adj EPS ⓘ	2.7	1.3	0.9	-0.8	0.1	5.9	11.8	6	6.6	7.7	0
YoY Gr.	-	-53.1%	-27.3%	-180.7%	NA	6466.7%	99.5%	-49.2%	10%	17.2%	-
BVPS (₹) ⓘ	10.1	11	12	11.1	11.6	17.5	23.1	27.2	34.2	42.6	0
Adj Net Profit ⓘ	28.5	13.4	9.7	-7.9	1	61.7	123	63.6	70	82	NAN
Cash Flow from Ops. ⓘ	0.8	104	83.6	40.8	51.9	70.2	108	172	-0.1	87.4	-
Debt/CF from Ops. ⓘ	157.7	2.1	3.2	6.1	5.1	3.3	2.1	0.9	-1944.1	2.4	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5%	9%	6%	7.5%
Adj EPS ⓘ	12.2%	143.6%	-13.2%	17.2%
BVPSⓘ	17.3%	29.8%	22.6%	24.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	30.6	12.1	8.1	-6.5	0.8	40.7	58.1	24	21.5	20.1	0
Op. Profit Mgn % ⓘ	13	10	13.3	9.3	10	16.4	25.5	20.2	18.6	20.4	NAN
Net Profit Mgn % ⓘ	5.8	2.8	2.4	-1.9	0.2	8.7	19.2	12.1	9.9	10.8	NAN
Debt to Equity ⓘ	1.2	1.9	2.1	2.1	2.2	1.3	0.9	0.5	0.5	0.5	-
Working Cap Days ⓘ	98	128	169	183	168	145	185	211	184	214	0
Cash Conv. Cycle ⓘ	54	71	93	116	111	84	95	111	99	126	0

Recent Performance Summary

Recent Performance Summary not available for IPO

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	706	-
BVPS (₹) ⓘ	0	-
Reserves (₹ Cr.) ⓘ	175	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	- / -
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	-
Industry PE ⓘ	45.3

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Shiva Pharmachem - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	490.34	469.96	413.21	421.97	495.06	705.87	639.81	527.74	708.61	761.70
Operating Expenses ⓘ +	426.83	422.94	358.47	382.54	445.67	590.29	476.67	421.05	576.65	606.22
Manufacturing Costs	15.25	12.69	14.49	26.97	24.54	32.30	41.96	36.53	67.01	75.50
Material Costs	378.29	353.29	268.92	284.40	334.75	455.41	323.14	270.35	375.63	384.62
Employee Cost	11.97	15.52	28.48	33.89	37.60	41.35	47.50	55.47	65.48	68.03
Other Costs ⓘ	21.33	41.45	46.58	37.28	48.78	61.23	64.07	58.70	68.53	78.07
Operating Profit ⓘ	63.51	47.01	54.74	39.42	49.39	115.58	163.14	106.69	131.96	155.48
Operating Profit Margin (%)	13.0%	10.0%	13.2%	9.3%	10.0%	16.4%	25.5%	20.2%	18.6%	20.4%
Other Income ⓘ +	3.67	5.90	10.28	8.56	12.32	8.78	37.86	15.37	12.68	12.98
Exceptional Items ⓘ	0	-0.33	0	0	0	0	-0.87	0	0	0
Interest ⓘ	15.34	9.96	23.13	20.52	22.39	20.78	14.11	7.45	6.67	9.73
Depreciation ⓘ	8.45	19.08	27.72	34.61	37.37	32.88	28	22.60	37.32	35.48
Profit Before Tax ⓘ	43.38	23.54	14.17	-7.15	1.94	70.70	158.01	92.01	100.65	123.25
Tax ⓘ	14.78	8.24	-0	-1.85	-2.78	8.94	29.26	24.27	25.94	34.13
Profit After Tax	28.59	15.30	14.17	-5.30	4.73	61.76	128.75	67.74	74.71	89.12
PAT Margin (%)	5.8%	3.3%	3.4%	-1.3%	1.0%	8.8%	20.1%	12.8%	10.5%	11.7%
Adjusted EPS (₹)	2.7	1.5	1.4	-0.5	0.5	5.9	12.4	6.4	7.0	8.4
Dividend Payout Ratio (%)	12%	23%	22%	-66%	0%	0%	15%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund +	105.43	114.87	125.28	115.80	120.53	182.28	240.60	288.99	363.37	452.14
Share Capital ⓘ	6.95	6.95	6.95	6.95	6.95	6.95	6.95	7.08	7.08	21.24
Reserves ⓘ	98.48	107.92	118.33	108.85	113.58	175.33	233.65	281.91	356.29	430.90
Debt +	128.04	191.95	240.04	224.20	240.82	212.78	210.59	148.92	176.08	198.25
Long Term Debt	45.75	78.49	91.10	68.65	75.93	66.23	56.47	50.34	34.49	9.38
Short Term Debt	82.29	113.46	148.94	155.55	164.90	146.55	154.12	98.58	141.59	188.87
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	37.43	31.45	42.38	29	43.06	80.15	45.73	57.01	84.20	64.57
Others Liabilities ⓘ	16.88	33.38	42.54	39.84	37.02	48.06	44.98	50.58	74.86	74.31
Total Liabilities ⓘ	287.78	371.65	450.24	408.85	441.43	523.27	541.89	545.50	698.50	789.28
Fixed Assets
Net Fixed Assets ⓘ +	71.03	113.39	157.42	176.77	165.88	151.23	112.50	173.08	178.34	179.54
Gross Block	104.39	159.75	231.50	285.53	311.27	329.10	289.39	371.26	413.05	449.39
Accumulated Depreciation	33.36	46.35	74.07	108.76	145.39	177.87	176.89	198.18	234.71	269.85
CWIP ⓘ	47.56	53.99	26.02	5.93	2.58	19.11	53.47	35.50	40.28	84.01
Investments ⓘ	0.17	0.84	12.61	12.61	12.66	20.28	28.75	40.09	40.99	57.42
Inventories	28.92	38.48	50.60	55.91	48.38	77.48	63.45	74.01	108.34	102.65
Trade Receivables	104.81	98.03	118.88	118.60	160.78	191.35	179.64	142.39	234.12	273.87
Cash Equivalents	10.67	19.22	41.77	2.49	16.30	15.26	16.33	17.76	5.01	7.42
Others Assets ⓘ	24.62	47.69	42.94	36.53	34.86	48.56	87.75	62.66	91.42	84.37
Total Assets ⓘ	287.78	371.65	450.24	408.85	441.43	523.27	541.89	545.50	698.50	789.28

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ +	0.81	104.46	83.63	40.83	51.91	70.18	108.09	172.18	-0.10	87.38
PBT ⓘ	43.38	23.86	14.17	-7.15	1.94	70.70	158.01	92.01	100.65	123.25
Adjustment ⓘ	22.78	28.26	50.54	54.63	59.55	51.98	23.69	28.04	41.58	40.01
Changes in Working Capital ⓘ	-34.63	60.58	24.94	-1.4	-20.18	-11.12	-3.48	82.1	-142.33	-75.88
Tax Paid ⓘ	-15.37	-8.24	-6	-5.25	0	-11.82	-31.12	-29.97	0	0
Cash Flow From Investing Activity ⓘ +	-40.48	-82.35	-55.55	-33.87	-23.17	-42.39	-32.11	-68.63	-47.30	-92.91
Capex	-40.48	-81.68	-43.78	-33.87	-23.13	-34.77	-23.64	-71.14	-47.27	-80.55
Net Investments	0	-0.67	-11.78	0	0	0	0	0.04	-0.90	-12.42
Others ⓘ	-0.01	0	0	0	-0.05	-7.62	-8.48	2.48	0.87	0.06
Cash Flow From Financing Activity ⓘ +	31.52	-13.56	-5.53	-46.55	-14.93	-28.83	-74.92	-99.99	36.45	7.94
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0.13	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	-15.85	-25.11
Interest Paid ⓘ	-0.88	0	0	-20.46	0.21	1.68	1.99	-7.45	-5.73	-9.10
Dividend Paid ⓘ	-3.48	-3.48	-3.13	-3.48	0	0	-23.46	0	0	0
Others ⓘ	35.87	-10.08	-2.40	-22.62	-15.13	-30.51	-53.57	-92.54	58.03	42.14
Net Cash Flow ⓘ	-8.16	8.55	22.55	-39.59	13.81	-1.04	1.06	3.56	-10.95	2.40

Finance Ratio

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	30.69	13.89	11.8	-4.4	4	40.79	60.89	25.58	22.91	21.86
ROCE (%)	28.75	11.89	10.33	3.54	6.5	22.85	39.18	22.07	21.63	21.89
Asset Turnover Ratio	2.01	1.48	1.04	0.98	1.16	1.46	1.2	0.97	1.14	1.02
PAT to CFO Conversion(x)	0.03	6.83	5.9	N/A	10.97	1.14	0.84	2.54	-0	0.98
Working Capital Days
Receivable Days	65	76	92	103	103	91	106	111	97	122
Inventory Days	19	25	38	46	38	33	40	48	47	51
Payable Days	33	36	50	46	39	49	71	69	69	71

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Shiva Pharmachem Ltd FAQs

The current trading price of Shiva Pharmachem on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Shiva Pharmachem stood at ₹0.00 Cr

The latest P/E ratio of Shiva Pharmachem as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Shiva Pharmachem as of 31-Dec-1969 is 0.00.

The 52-week high of Shiva Pharmachem is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shiva Pharmachem is ₹706 ( Cr.) .

About Shiva Pharmachem Ltd

No data to display

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Shiva Pharmachem Ltd Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating